薬剤溶出性バルーンカテーテルの世界市場レポート 2025年

薬剤溶出性バルーンカテーテルの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR12.0％で26億1,000万米ドルに成長します。予測期間の成長は、呼吸器疾患の継続的成長、老年人口の拡大、意識と教育の向上、新興国での市場拡大、カスタマイズされた薬剤処方、規制サポートとコンプライアンス、パッケージングとデザインの革新に起因すると考えられます。予測期間における主な動向には、スマート吸入器と接続性、呼吸作動式吸入器へのシフト、小児および老年患者のニーズへの注目、生物製剤送達、環境に優しい吸入器設計などが含まれます。

末梢および心血管疾患の有病率の増加は、今後の薬剤溶出バルーンカテーテル市場の成長を促進すると予想されます。心血管疾患（CVD）には、心臓や循環系に影響を及ぼすさまざまな疾患が含まれ、末梢動脈疾患（PAD）には、主に腕や脚への血流を減少させる動脈の狭窄が含まれます。薬剤溶出性バルーンカテーテルは冠動脈疾患（CAD）の治療に使用され、血管内に入ると抗再狭窄効果を発揮する抗増殖剤が塗布されたセミコンプライアント血管形成術用バルーンが特徴です。例えば、2024年5月、米国の政府機関である疾病対策予防センター（CDC）は、2022年には心臓病が702,880人の死亡の原因となっており、これは死亡者の5人に1人に相当すると報告しました。米国では年間約80万5,000人が心臓発作を起こし、そのうち約60万5,000人が初めての心臓発作で、20万人が過去に心臓発作を起こしたことがある人です。このように、末梢および心血管疾患の有病率の上昇が、薬剤溶出バルーンカテーテル市場を後押ししています。

低侵襲手技に対する需要の増加は、薬剤溶出バルーンカテーテル市場の成長をさらに促進すると予想されます。低侵襲手術は、小さな切開を伴う手術手技であり、治癒時間の短縮、痛みの軽減、感染リスクの低減をもたらします。薬剤溶出性バルーンはこうした治療において極めて重要であり、治療部位に直接薬剤を送り込むことで再狭窄を予防し、血管インターベンションの効果を高める。例えば、Intuitive Surgical Inc.は、Vinci手術システムを使用した手術件数が2021年の1,594,000件から2022年には1,875,000件に18％増加すると報告しています。さらに、米国形成外科学会は、米国における美容目的の低侵襲手術が2022年には23,672,269件に増加すると指摘しています。したがって、低侵襲手術の需要の増加が薬剤溶出性バルーンカテーテル市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界薬剤溶出性バルーンカテーテルPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の薬剤溶出性バルーンカテーテル市場：成長率分析
• 世界の薬剤溶出性バルーンカテーテル市場の実績：規模と成長, 2019-2024
• 世界の薬剤溶出性バルーンカテーテル市場の予測：規模と成長, 2024-2029, 2034F
• 世界薬剤溶出性バルーンカテーテル総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の薬剤溶出性バルーンカテーテル市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 冠動脈疾患薬剤溶出バルーンカテーテル
• 末梢血管疾患薬剤溶出バルーンカテーテル
• 世界の薬剤溶出性バルーンカテーテル市場薬物による、実績と予測, 2019-2024, 2024-2029F, 2034F
• パクリタキセル
• シロリムス
• その他の薬物
• 世界の薬剤溶出性バルーンカテーテル市場：原材料別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ナイロン
• ポリウレタン
• その他の原材料
• 世界の薬剤溶出性バルーンカテーテル市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 外来手術センター
• カテーテル検査室
• 世界の薬剤溶出性バルーンカテーテル市場、冠動脈疾患のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬剤溶出バルーンカテーテル
• プレーンバルーンカテーテル
• 世界の薬剤溶出性バルーンカテーテル市場、末梢血管疾患のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬剤溶出バルーンカテーテル
• 血管形成術用バルーンカテーテル
• 世界の薬剤溶出性バルーンカテーテル市場、血管形成術用バルーンカテーテルのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬剤溶出型血管形成術用バルーンカテーテル

第7章 地域別・国別分析

• 世界の薬剤溶出性バルーンカテーテル市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の薬剤溶出性バルーンカテーテル市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 薬剤溶出性バルーンカテーテル市場：競合情勢
• 薬剤溶出性バルーンカテーテル市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• B Braun Melsungen Aktiengesellschaft
• Terumo Corporation
• Cook Medical LLC
• Lepu Medical Technology Co. Ltd.
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• BIOTRONIK SE & Co. KG
• Acotec Scientific Co. Ltd.
• Cordis Corporation
• Biosensors International Group Ltd.
• Zylox-Tonbridge Medical Technology Co. Ltd.
• Mermaid Medical AS
• Hexacath Limited
• Zhejiang Barty Medical Technology Co. Ltd.
• Cardionovum GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 薬剤溶出性バルーンカテーテル市場2029：新たな機会を提供する国
• 薬剤溶出性バルーンカテーテル市場2029：新たな機会を提供するセグメント
• 薬剤溶出性バルーンカテーテル市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A drug-eluting balloon catheter is a medical device utilized in the treatment of coronary artery disease through percutaneous coronary intervention (PCI). It is a semi-compliant angioplasty balloon that is coated with an anti-proliferative drug. During inflation, the drug is released into the vessel wall, aiming to prevent restenosis and reduce the risk of late thrombosis without the need for implanting a permanent foreign object.

The main types of drug-eluting balloon catheters include those designed for coronary artery disease and peripheral vascular disease. Coronary artery disease drug-eluting balloon catheters deliver antiproliferative drugs directly to the vessel wall using a lipophilic matrix, eliminating the need for a permanent structure such as a metal prosthesis or persistent polymer. Various drugs such as paclitaxel and sirolimus are used, and the catheters are made from raw materials such as nylon, polyurethane, and others. They find applications in hospitals, clinics, ambulatory surgical centers, and catheterization laboratories.

The drug eluting balloons catherers market research report is one of a series of new reports from The Business Research Company that provides drug eluting balloons catherers market statistics, including drug eluting balloons catherers industry global market size, regional shares, competitors with a drug eluting balloons catherers market share, detailed drug eluting balloons catherers market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting balloons catherers industry. This drug eluting balloons catherers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug eluting balloons catheters market size has grown rapidly in recent years. It will grow from $1.43 billion in 2024 to $1.66 billion in 2025 at a compound annual growth rate (CAGR) of 16.0%. The growth in the historic period can be attributed to increasing respiratory disorders, advantages over traditional inhalers, patient preference for dpis, government initiatives for respiratory health, strategic collaborations and partnerships, advancements in drug formulations, rising geriatric population.

The drug eluting balloons catheters market size is expected to see rapid growth in the next few years. It will grow to $2.61 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to continued growth in respiratory disorders, expanding geriatric population, increasing awareness and education, market expansion in emerging economies, customized drug formulations, regulatory support and compliance, innovations in packaging and design. Major trends in the forecast period include smart inhalers and connectivity, shift towards breath-actuated inhalers, focus on pediatric and geriatric patient needs, biologics delivery, environmentally friendly inhaler designs.

The increasing prevalence of peripheral and cardiovascular diseases is anticipated to drive the growth of the drug-eluting balloon catheter market in the future. Cardiovascular diseases (CVDs) encompass a range of conditions affecting the heart and circulatory system, while peripheral artery disease (PAD) specifically involves the narrowing of arteries that diminishes blood flow mainly to the arms or legs. Drug-eluting balloon catheters are utilized in the treatment of coronary artery disease (CAD); they feature a semi-compliant angioplasty balloon coated with an anti-proliferative agent that exerts an anti-restenotic effect upon entering the vessel. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that in 2022, heart disease was responsible for 702,880 deaths, representing 1 in every 5 fatalities. Annually, around 805,000 individuals in the United States suffer a heart attack, with approximately 605,000 being their first heart attack and 200,000 occurring in those who have previously experienced one. Thus, the rising prevalence of peripheral and cardiovascular diseases is propelling the drug-eluting balloon catheter market.

The increasing demand for minimally invasive procedures is expected to further propel the growth of the drug-eluting balloon catheter market. Minimally invasive procedures involve surgical techniques with small incisions, resulting in reduced healing time, less pain, and lower infection risks. Drug-eluting balloons are crucial in these procedures, delivering medication directly to the treatment area to prevent restenosis and enhance the effectiveness of vascular interventions. For instance, Intuitive Surgical Inc. reported an 18% increase in surgical procedures using Vinci surgical systems from 1,594,000 in 2021 to 1,875,000 in 2022. Additionally, the American Society of Plastic Surgeons noted a rise in cosmetic minimally invasive procedures in the US to 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the drug-eluting balloon catheter market.

Key players in the drug-eluting balloon catheter market are intensifying their efforts to develop next-generation products with advanced technologies to secure a competitive advantage. For instance, in March 2024, Boston Scientific Corporation, a U.S.-based biomedical and biotechnology engineering firm, announced it had received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB). This product is the first drug-coated coronary balloon available in the U.S. specifically designed for treating in-stent restenosis (ISR), a condition where plaque or scar tissue obstructs a previously stented vessel. The AGENT DCB features a paclitaxel coating that provides a therapeutic dose to the vessel wall, effectively reducing ISR recurrence without the need for additional stents or radiation. Clinical trials demonstrated a 49% reduction in the risk of heart attack at the target site, along with low rates of adverse events.

In June 2023, Translumina Therapeutics Company acquired Blue Medical Devices BV for an undisclosed amount. This strategic acquisition aimed to integrate Blue Medical's unique drug application technology into Translumina's product lines, expanding offerings in neurovascular and peripheral interventions and enhancing drug coating capabilities. Blue Medical Devices BV is a Netherlands-based medical device company specializing in producing drug-eluting balloon catheters.

Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB

North America was the largest region in the drug eluting balloons catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug-eluting balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug-eluting balloon catheter market consists of sales of everolimus and stellarex. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Eluting Balloons Catheters Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug eluting balloons catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug eluting balloons catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug eluting balloons catheters market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters; Peripheral Vascular Disease Drug-Eluting Balloon Catheters
• 2) By Drug: Paclitaxel; Sirolimus; Other Drugs
• 3) By Raw Material: Nylon; Polyurethane; Other Raw Materials
• 4) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Catheterization Laboratories
• Subsegments:
• 1) By Coronary Artery Disease: Drug-Eluting Balloon Catheters; Plain Balloon Catheters
• 2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters; Angioplasty Balloon Catheters
• 3) By Angioplasty Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters
• Companies Mentioned: Abbott Laboratories; Medtronic PLC; Becton Dickinson and Company; Koninklijke Philips NV; Boston Scientific Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Eluting Balloons Catheters Market Characteristics

3. Drug Eluting Balloons Catheters Market Trends And Strategies

4. Drug Eluting Balloons Catheters Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Drug Eluting Balloons Catheters Growth Analysis And Strategic Analysis Framework

• 5.1. Global Drug Eluting Balloons Catheters PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Drug Eluting Balloons Catheters Market Growth Rate Analysis
• 5.4. Global Drug Eluting Balloons Catheters Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Drug Eluting Balloons Catheters Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Drug Eluting Balloons Catheters Total Addressable Market (TAM)

6. Drug Eluting Balloons Catheters Market Segmentation

• 6.1. Global Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coronary Artery Disease Drug-Eluting Balloon Catheters
• Peripheral Vascular Disease Drug-Eluting Balloon Catheters
• 6.2. Global Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Paclitaxel
• Sirolimus
• Other Drugs
• 6.3. Global Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nylon
• Polyurethane
• Other Raw Materials
• 6.4. Global Drug Eluting Balloons Catheters Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Ambulatory Surgical Centers
• Catheterization Laboratories
• 6.5. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Coronary Artery Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Eluting Balloon Catheters
• Plain Balloon Catheters
• 6.6. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Peripheral Vascular Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Eluting Balloon Catheters
• Angioplasty Balloon Catheters
• 6.7. Global Drug Eluting Balloons Catheters Market, Sub-Segmentation Of Angioplasty Balloon Catheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Eluting Angioplasty Balloon Catheters

7. Drug Eluting Balloons Catheters Market Regional And Country Analysis

• 7.1. Global Drug Eluting Balloons Catheters Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Drug Eluting Balloons Catheters Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Eluting Balloons Catheters Market

• 8.1. Asia-Pacific Drug Eluting Balloons Catheters Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Eluting Balloons Catheters Market

• 9.1. China Drug Eluting Balloons Catheters Market Overview
• 9.2. China Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Eluting Balloons Catheters Market

• 10.1. India Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Eluting Balloons Catheters Market

• 11.1. Japan Drug Eluting Balloons Catheters Market Overview
• 11.2. Japan Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Eluting Balloons Catheters Market

• 12.1. Australia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Eluting Balloons Catheters Market

• 13.1. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Eluting Balloons Catheters Market

• 14.1. South Korea Drug Eluting Balloons Catheters Market Overview
• 14.2. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Eluting Balloons Catheters Market

• 15.1. Western Europe Drug Eluting Balloons Catheters Market Overview
• 15.2. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Eluting Balloons Catheters Market

• 16.1. UK Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Eluting Balloons Catheters Market

• 17.1. Germany Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Eluting Balloons Catheters Market

• 18.1. France Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Eluting Balloons Catheters Market

• 19.1. Italy Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Eluting Balloons Catheters Market

• 20.1. Spain Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Eluting Balloons Catheters Market

• 21.1. Eastern Europe Drug Eluting Balloons Catheters Market Overview
• 21.2. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Eluting Balloons Catheters Market

• 22.1. Russia Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Eluting Balloons Catheters Market

• 23.1. North America Drug Eluting Balloons Catheters Market Overview
• 23.2. North America Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Eluting Balloons Catheters Market

• 24.1. USA Drug Eluting Balloons Catheters Market Overview
• 24.2. USA Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Eluting Balloons Catheters Market

• 25.1. Canada Drug Eluting Balloons Catheters Market Overview
• 25.2. Canada Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Eluting Balloons Catheters Market

• 26.1. South America Drug Eluting Balloons Catheters Market Overview
• 26.2. South America Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Eluting Balloons Catheters Market

• 27.1. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Eluting Balloons Catheters Market

• 28.1. Middle East Drug Eluting Balloons Catheters Market Overview
• 28.2. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Eluting Balloons Catheters Market

• 29.1. Africa Drug Eluting Balloons Catheters Market Overview
• 29.2. Africa Drug Eluting Balloons Catheters Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Drug Eluting Balloons Catheters Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Drug Eluting Balloons Catheters Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Eluting Balloons Catheters Market Competitive Landscape And Company Profiles

• 30.1. Drug Eluting Balloons Catheters Market Competitive Landscape
• 30.2. Drug Eluting Balloons Catheters Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Drug Eluting Balloons Catheters Market Other Major And Innovative Companies

• 31.1. B Braun Melsungen Aktiengesellschaft
• 31.2. Terumo Corporation
• 31.3. Cook Medical LLC
• 31.4. Lepu Medical Technology Co. Ltd.
• 31.5. Meril Life Sciences Pvt. Ltd.
• 31.6. MicroPort Scientific Corporation
• 31.7. BIOTRONIK SE & Co. KG
• 31.8. Acotec Scientific Co. Ltd.
• 31.9. Cordis Corporation
• 31.10. Biosensors International Group Ltd.
• 31.11. Zylox-Tonbridge Medical Technology Co. Ltd.
• 31.12. Mermaid Medical AS
• 31.13. Hexacath Limited
• 31.14. Zhejiang Barty Medical Technology Co. Ltd.
• 31.15. Cardionovum GmbH

32. Global Drug Eluting Balloons Catheters Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Eluting Balloons Catheters Market

34. Recent Developments In The Drug Eluting Balloons Catheters Market

35. Drug Eluting Balloons Catheters Market High Potential Countries, Segments and Strategies

• 35.1 Drug Eluting Balloons Catheters Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Drug Eluting Balloons Catheters Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Drug Eluting Balloons Catheters Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer